Eli Lilly's bebtelovimab isn't likely to work against the forms of omicron that are currently dominant in the US, according to the FDA https://t.co/uuZywQZBM7— Bloomberg (@business) November 30, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


